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INTRODUCTION 
The increasing use of antibiotics since their discovery is not without its penalties. The 
dawn of antimicrobial resistance, alongside antibiotic induced super infections, such as 
Clostridium difficile (C. difficile) associated diarrhoea, has called for more strict and 
robust antimicrobial stewardship. Antimicrobial stewardship aims to promote the rational 
use of antibiotics by ensuring that the most appropriate antibiotic is chosen, at the 
correct dose by the correct route for the correct time1.  
 
One aspect of antimicrobial stewardship is the application of antibiotic intravenous to 
oral switch guidelines2. Since the late 1980’s there has been a plethora of research into 
the benefits of employing an early intravenous to oral switch policy for antibiotics.  
These benefits include the facilitation of early discharge from hospital3, a reduced risk of 
cannula associated adverse events4, reduced spend on medication5,6, and a shorter 
time required for administering the medication. These benefits are observed due to a 
reduction in the course length of intravenous antibiotics. For example, in the studies by 
Ramirez et al3 and McLaughlin et al5, the implementation of antibiotic guidelines 
facilitating early intravenous to oral switch was associated with a 29-33% reduction in 
the course lengths of intravenous antibiotics in patients with community acquired 
pneumonia. The implementation of IV to oral switch antibiotic guidelines has been 
shown to speed up the time taken from when the patient is first eligible for oral 
antibiotics to the prescription being changed7. Furthermore shorter intravenous courses 
prior to oral therapy in medical patients, with predominantly respiratory infections, have 
been shown to reduce the median duration of hospital stay from 13 to 10 days5. There 
has been some speculation that this may decrease the incidence of healthcare 
associated infections such as C. difficile8 although there is no evidence to directly 
support this correlation in the literature. 
 
A potential risk of the intravenous to oral switch may include the switch occurring too 
early, resulting in an inadequate treatment of the infection and thus clinical deterioration. 
Ramirez et al3 reported only one treatment failure (following early intravenous to oral 
switch) out of 118 patients with community acquired pneumonia; however this patient 
had multiple respiratory pathologies. In this case intravenous therapy was resumed. In 
another study 7 of 66 patients undergoing early intravenous to oral switch for 
community acquired pneumonia were readmitted but none were for infectious causes6.  
 
It is important to acknowledge that the intravenous to oral switch is not appropriate in all 
patients. For treatment of certain infections, such as endocarditis and osteomyelitis, 
high antibiotic tissue concentrations are needed and therefore intravenous therapy is 
essential. An intravenous to oral switch in these infections would likely have a significant 
negative clinical impact.  Alternatively there are some oral antibiotics which have a high 
bioavailability, thus the equivalent intravenous formulation appears costly to use with no 
extra clinical benefit. Sequential therapy programs have been undertaken with 
quinolones for this reason showing that significant cost savings can be made by 
reducing the usage of intravenous formulations by 60%9. In this study the intravenous 
route was reserved only for the seriously ill or those with intestinal diseases that 
prevented sufficient oral absorption.  
 
It is therefore essential that antibiotic intravenous to oral switch guidelines include 
various criteria to ensure that a switch is appropriate. These range from acknowledging 
clinical improvement to assessing the safety and practicality of the oral route. 
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Consideration must also be made to which oral antibiotic would be most appropriate as 
in some cases there are not comparable oral formulations. Pharmacists are well placed 
to offer advice on available formulations and pharmacokinetic considerations in 
switching to oral equivalents. They also play roles as antimicrobial specialist 
pharmacists involved in designing and implementing the guidelines as well as 
dispensing pharmacists who may be required to enforce the restrictions on antibiotic 
supply outlined by guidelines10.  
 
Antibiotic restriction may be one method of regulating the use of intravenous antibiotics 
however multidisciplinary engagement is likely to be essential for trust-wide guideline 
adherence. Physician involvement in intravenous to oral switch programmes has 
previously been thought to be vital in clarifying the legitimacy of the programme to 
medical colleagues less they believe it to be simply a cost-saving exercise led by 
pharmacists10. Whilst barriers reported by doctors concerning optimal antibiotic use for 
community acquired pneumonia have included a lack of familiarity with the guideline, 
belief that intravenous therapy is more efficacious, concern about re-infection and a 
desire to let senior physicians make the decision11, the barriers to intravenous to oral 
switch guideline adherence have received little attention in the literature. 
 
At a large teaching hospital in South West England, a guideline for intravenous to oral 
switch was developed in 2007, taking into consideration the evidence discussed above.  
However, a re-audit completed in 2009 demonstrated that there was persistent poor 
adherence to the guideline12. The aim of this study, completed in 2010-2011, was 
therefore to identify the barriers of doctors, nurses and pharmacists to adhering to the 
guideline and to explore their possible solutions to overcome these barriers. 
 
Due to the number of healthcare professionals involved in antibiotic therapy, it was 
decided that a multidisciplinary consensus was required on the prohibitive and enabling 
contributors to the timely switch of intravenous to oral antibiotics in accordance with 
local and national guidelines.   
 
METHODS 
The study was conducted at University Hospitals Bristol NHS Foundation Trust, a large 
teaching hospital and tertiary referral centre for cardiology, paediatrics and oncology. 
The North Somerset and South Bristol Research Ethics Committee deemed the study to 
be service development and hence ethical approval was not required. 
 
The method comprised a three round Delphi study (one explorative and two iterative 
rounds) which was initiated in late spring 2010 and semi-structured interviews.  The 
latter were conducted in parallel to the Delphi study as it is generally recognised that the 
Delphi technique should not be used in isolation13. This approach was chosen in order 
to generate a consensus across disciplines, to allow the participation of various 
healthcare professionals irrespective of shift-working and to prevent bias and social 
pressures between profession and grade.  
 
Delphi Study: The Expert Panel 
The expert panel was purposively sampled from qualified doctors, nurses and 
pharmacists who had daily involvement with intravenous antibiotic prescriptions. Ten 
participants from each profession were invited to participate in line with previous Delphi 
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studies in the healthcare setting14. The participants were selected to evenly represent a 
variety of grades over the 4 directorates: oncology and haematology, medicine, surgery 
and cardiology (table 1). Random selection of these staff was not possible due to shift 
working, incomplete staffing lists, an ever changing work force and in some cases too 
few staff in certain positions for example pharmacists in cardiology. It was decided not 
to include microbiologists as, although they have expert knowledge in the field of 
antibiotics, their role as consultants limits their daily exposure to the practicalities of the 
intravenous to oral switch guideline at ward level.  Including “illusory expertise” in the 
expert panel has previously been cited as a basic pitfall of the Delphi technique15.   
 
The expert panel were advised that during the study they should not discuss the 
intravenous to oral switch guideline with other panel members. They were encouraged 
to contact the investigator if more time was required to complete each round or if any 
clarification was needed. All participants were sent correspondence via e-mail outlining 
information about the study prior to the first round. Completion and return of the study 
material was taken to imply consent as fully informed consent, in the case of 
questionnaires, can often only be achieved once the participants have examined the 
material16. 
 
Delphi First Round 
The correspondence for the first and subsequent rounds was distributed by e-mail with 
a two week deadline for responses. All rounds were piloted by a pharmacist 
independent of the expert panel and any ambiguities were resolved prior to distribution. 
 
In round one, free text responses were invited to the following open questions: 
1) What barriers prevent a switch from the intravenous to oral route in line with 
guideline suggestions? 
2) What could be done to improve adherence to the antibiotic intravenous to oral 
switch guideline based on the barriers you have identified? 
 
The resulting comments were anonymised and split into two categories: barriers to 
adherence and solutions to poor adherence. Each category was thematically analysed 
by the principal investigator, the senior antimicrobial pharmacist and the clinical 
pharmacy manager. Identical themes were grouped together and formatted into 
statements of around 20-25 words which has been shown to encourage optimal 
consensus in Delphi studies15. 
 
Delphi Second Round 
The Delphi statements resulting from round one were formulated into a questionnaire in 
which the expert panel were asked to rate the importance of each statement on a five 
point ordinal scale, from irrelevant to very important, as used by Roos and Weardon17. 
In addition to rating the level of agreement with each statement, the members of the 
expert panel were invited to justify their response or comment on each statement. They 
were advised that these would be anonymised and fed back to the expert panel in 
subsequent rounds. 
 
Delphi Third Round 
The purpose of the third round is to allow the members of the panel to re-score each 
statement based on the comments and group position from the previous round in order 
to generate greater consensus. The responses to round two were collated and 
presented in the final questionnaire (Figure 1). A linear scale, which is well described in 
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previous Delphi studies18,19, was used to present the results of the second round to the 
panel in the third round questionnaire. All justifications and comments were anonymised 
and included without editing. As there were no requests for clarification of any statement 
and no requests for inclusion of alternative themes, the statements remained 
unchanged between rounds.  
 
 
Data Analysis 
Data from members of the expert panel who did not complete all three rounds were 
excluded before analysis. The resulting data from Delphi rounds two and three were 
analysed using Microsoft® Excel® by quantifying each response (1 equated to irrelevant; 
5 to very important). The ordinal nature of the data dictated that the median be used to 
describe the response of the panel18-20. As in previous Delphi studies, the interquartile 
range (IQR) was used to describe the degree of agreement within the expert panel17,19 
with an IQR of 1 or less representing consensus17. Stability between rounds was 
determined by a change of less than 15% which has been considered the natural level 
of oscillation between consecutive Delphi rounds21. The differences in response 
between each profession were analysed using IBM SPSS Statistics (SPSS®) Version 
16. A Mann Whitney test was used to compare the response of doctors and 
pharmacists. 
 
Interviews 
Semi-structured interviews were conducted with doctors, nurses and pharmacists (who 
were not invited to participate in the Delphi study) to further explore the barriers to 
guideline adherence and solutions to poor adherence. The Delphi participants were not 
interviewed because individual ideas may have been lost to group consensus by nature 
of the Delphi process. Non-responders were not interviewed as it was presumed that 
they no longer wished to participate. One participant was purposively sampled from 
each of the three professions in turnuntil no new themes emerged.  
 
The initial interview schedule was informed by the responses to the first round of the 
Delphi study, the literature and the aims and objectives of the study. The original 
interview schedule was piloted on a pharmacist and any points of ambiguity resolved. 
The interviews were recorded and transcribed verbatim into Microsoft® Word®. The final 
transcript accuracy was checked by the principal investigator. The interviews were 
thematically analysed by the principal investigator and a coding tree was developed for 
each question. The themes identified from the interviews were then compared and 
contrasted with the Delphi study results. 
 
RESULTS 
 
Delphi 
Of the 30 members of the expert panel invited to participate, one declined after the 
introductory letter. Of the remaining 29 participants, 16 (55%) completed round one and 
13 (45%) completed all rounds. The resulting expert panel comprised four doctors and 
nine pharmacists; no nurses completed all rounds (table 1). 
 
Following round one, 18 statements concerning barriers and 17 statements concerning 
solutions were formulated and entered into the round two questionnaire template. The 
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statements remained unchanged throughout rounds two and three as there were no 
requests for clarification or rewording. 
 
Barriers 
Consensus was achieved for 14 statements (78%) following round three (table 2). The 
highest level of agreement with the median was achieved for statement B1 (76.9%). 
The level of consensus in round three, determined by a reduced IQR, improved for five 
statements (B1, B8, B9, B11 and B13) when compared with round two. Stability, less 
than 15% change between rounds two and three, was reached for all statements except 
statement B1. 
 
Solutions 
Consensus was achieved for 14 statements (82%) following round three (table 3). The 
highest level of agreement with the median was achieved for statement S12 (76.9%). 
The level of consensus improved for two statements (S4 and S11) between rounds 
however there was a divergence of opinion (increase in IQR) for S13. Stability between 
rounds was reached for all statements. 
 
Interprofessional differences  
There was no significant difference (p>0.05) between the median ratings of doctors and 
pharmacists for all but one statement. Statement B10 showed a difference of opinion 
between doctors and pharmacists (p=0.023) with doctors appearing to vote lower (two 
choosing irrelevant) in the raw data.  
 
Interviews 
Seven interviews were conducted including three with doctors, two with pharmacists 
and two with nurses at which point no new themes emerged. The barriers to guideline 
adherence were divided into three categories as identified previously in describing 
interview responses to questions concerning guideline adherence11: (1) Internal 
barriers: knowledge, (2) Internal barriers: attitude and (3) External barriers (table 4). The 
identified solutions are shown in table 5. The themes identified in the interviews were 
very similar to those identified by the Delphi study although some more specific 
solutions emerged. 
 
DISCUSSION 
The application of a Delphi study and semi-structured interviews was successful in 
identifying barriers to the antibiotic intravenous to oral switch guideline and solutions to 
poor guideline adherence. Within the Delphi study, consensus was achieved for 26 out 
of 35 statements, with the most important barrier being  a lack of appropriate antibiotic 
review at the weekend and the most important solution to raise guideline 
awareness.The findings of the Delphi study were in general well supported by those 
themes identified by the interviews. The combination of the Delphi technique with semi-
structured interviews was advantageous, especially with respect to more specific 
solutions on how to overcome the barriers to guideline adherence were identified in the 
interviews. The interviews also provided an opportunity for the views of nurses to be 
represented. It must also be recognised that by the nature of the Delphi technique, 
specific ideas from a few individuals may have been marginalised in favour of group 
consensus. 
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Participant fatigue is a well recognised limitation of the Delphi study22. The lack of 
nurses in the final Delphi expert panel limits the findings to those of the pharmacy and 
medical profession although the two nurses interviewed did identify how they could 
contribute in this area. It is possible that the method of communication by e-mail was 
not suitable for this group as computer access at ward level is restricted. Whilst the 
resulting expert panel comprised more pharmacists than doctors, which may have 
skewed the median, statistically there was no difference between professions except for 
statement B7. The anonymity of the panel encouraged all participants to judge the 
comments published between rounds with equal merit. Statement B1 did not achieve 
stability using the 15% change rule following round three, however it was decided that 
participant fatigue would be too great to benefit from distributing a fourth round 
containing only one statement. The use of IQR alone as a method for determining 
consensus is restrictive as it does not identify the few cases demonstrating bipolar or 
plural distributions i.e. where there is strong consensus in a particular group of 
participants23. One statement (“the initial indication for the antibiotics was not recorded 
by the prescribing doctor”) has been noticed to show a bipolar distribution during data 
analysis. Here, equal participants selected important and not important with pharmacists 
and doctors represented equally in both groups. Using the IQR does not give a robust 
way to identify all of these alternative distributions.  
 
The most important barrier to antibiotic intravenous to oral switch guideline adherence 
was perceived to be lack of appropriate review at the weekends. Methods for adequate 
provision of information with which to inform a switch to oral antibiotics at the weekend 
should be investigated in the future. Due to limited medical staffing at the weekend it 
may be necessary to look further afield than simple provision of information to a 
conditional switch plan which is documented in the medical notes and may be 
supported in certain areas by a patient group direction. 
 
All of the statements (n=7) where consensus was not reached concerned specific roles 
for a particular profession. This may be due to differences between the perception of 
each profession for their own and the other professions responsibilities. Such 
differences could be a draw-back of the method used but may also highlight that 
individuals are not aware of the scope of each profession concerning the intravenous to 
oral switch guideline. 
 
There were no statements (barriers or solutions) pertaining to the involvement of nurses 
in the antibiotic intravenous to oral switch from the Delphi study. This is possibly due to 
the lack of nurse respondents to the Delphi which may cast doubt over their perceived 
role in the switch process. There is little information in the literature concerning nurses 
attitudes towards the intravenous to oral switch process and so it is difficult to postulate 
whether the Delphi results would be different with nurse involvement. However the 
nurses interviewed were clear in their roles of highlighting those patients on intravenous 
antibiotics for over 48 hours and prompting medical review. Gillespie et al24 showed that 
the involvement of nurses in antimicrobial stewardship education sessions and 
awareness campaigns improved awareness of resistance from 59% to 79% and of line 
infection due to antibiotic therapy from 38% to 70%. This correlated to a reduction in line 
days for  3 of the 6 wards studied and a reduction from 3 line-related infections to 2 after 
the intervention. It is apparent that nurses are well placed to identify intravenous 
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antibiotic prescriptions that are due for review due to regular medication rounds and 
patient observation monitoring throughout the day. Engaging the nurses in antimicrobial 
stewardship using these strategies is likely to be necessary at the study hospital in 
order to improve adherence to the IV to oral switch guideline. 
The interviews alone revealed that doctors are sometimes unaware of which patients 
are on intravenous antibiotics and therefore those to whom the guideline applies. This 
view did not emerge through the Delphi study, perhaps through concern that other 
healthcare professionals would deem this sub-standard practice. The solutions 
identified through interviews included several point of switch reminders such as stickers 
affixed to the medication chart, which have been shown to reduce the average course of 
intravenous antibiotics from over 10 days to 8.4 days25 if placed on day 7.  
The role of pharmacists in the antibiotic intravenous to oral switch has previously 
ranged from design and implementation of switch guidelines5 to prompting review by 
doctors. Over 60% of the expert panel felt that pharmacy staff are not confident to 
encourage the intravenous to oral switch (statement B10). This is consistent with 
previous literature which showed that 58% of pharmacists agreed that a ‘lack of 
training/confidence’ was a reason for not applying the policy26. Out of the four doctors 
one felt that this was an important barrier whilst the other three chose ‘unsure’. This 
highlights an area where pharmacists may benefit from specific training with support 
from specialist antibiotic pharmacists. 
 
The proposal that all intravenous antibiotics should be automatically switched from the 
intravenous to oral route at 48 hours via the Delphi study met with significant opposition. 
Comments received from a registrar (with an interest in infectious disease) suggest that 
this approach would compromise patient safety “patients with conditions like 
endocarditis should not suffer due to doctors poor prescribing habits”. This view 
highlights that guidelines need to balance promoting good prescribing practice and 
upholding high standards of patient care whilst not letting poor prescribing go un-
challenged. The use of antibiotics in less serious infections however has been shown to 
benefit through the use of a patient group direction (PGD) where nurses can facilitate 
the switch reducing the median IV antibiotic therapy from 4 to 3 days for uncomplicated 
cellulitis in an outpatient setting27. Whilst the use of a PGD effectively empowers 
nursing staff to act on the guideline more work is required to determine if this approach 
would be as successful in secondary care. 
 
Engaging guideline users is an ever growing challenge due to the multitude of clinical 
guidelines released every year. Recent measures of good antimicrobial stewardship 
have encouraged the application of around seven different guidelines, one of which is 
an antibiotic intravenous to oral switch guideline2. Methods for engaging guideline users 
proposed via the Delphi study included education sessions using interactive case 
studies (statement S7), education on the benefits of intravenous to oral switch 
(statement S6) and making the guideline more accessible on wards (statement S2). The 
interview findings mirror these solutions and introduce the additional idea of providing 
feedback to each consultant team on guideline adherence data and specific benefits 
such as cost saving. It has been shown that facilities with good clinical guideline 
adherence have better evidence of timely, individual, non-punitive and customisable 
audit feedback than lower performing facilities28. Doctors have previously agreed that 
this approach along with encouragement from senior doctors is likely to encourage the 
adherence to guidelines29.  
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CONCLUSIONS 
The study has been successful in identifying several barriers to guideline adherence 
and discovering several solutions that may improve adherence. The most important 
barrier highlighted was the difference in practice between weekday and weekend 
working. This should be the focus of effort in attempting to improve adherence to the 
intravenous to oral switch guideline initially. The most important proposed solution was 
perceived to be improving guideline awareness through various methods targeting all 
grades of doctors as well as further engaging nursing staff. Such solutions should be 
investigated individually in future work to determine which may have a lasting impact on 
guideline adherence.   
 
Whilst this study concentrated on the intravenous to oral switch guideline, some of the 
barriers and solutions identified are transferable to increasing adherence to all 
guidelines. The challenge to increase adherence to guidelines will only increase, as it is 
clear from the interviews that some healthcare professionals already feel overwhelmed, 
by the ever emerging barrage of clinical guidelines. This reinforces the need for 
healthcare professionals to produce concise well sign-posted guidelines which are 
efficiently disseminated to all professions involved.   
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Table 1: Demographics of the final expert panel compared with the initially selected panel 
Professio
n 
Seniority* 
Clinical specialty 
Oncolog
y 
Medicine 
Surger
y 
Cardiolog
y 
Doctor 
(male=3, 
female=1) 
Foundation 
training  
(Year 1-2) 
Early specialist 
training  
(Years 3-4) 
Advanced 
specialist 
training (Year 
5+) 
    
1/7  1/1 2/2 2/2 1/3 1/3 0/2 
Nurse 
(female=10
) 
Band 5 Band 6 Band 7 Band 8 
    
0/5 0/2 0/2 0/1 0/2 0/3 0/3 0/2 
Pharmacis
t 
(male=2, 
female=7) 
Band 6 Band 7 
Band 
8a 
Band 
8b Band 8c 
    
1/2 3/3 3/3 1/1 1/1 1/1 3/3 2/4 2/2 
*Doctor seniority based on consecutive years of training since qualifying. Pharmacist and nurse seniority based on the NHS Agenda 
for Change scale. Nurse seniority ranges from newly qualified registered nurse (band 5) to matron (band 8a). Pharmacist seniority 
ranges from newly qualified pharmacist (band 6) to the trustwide clinical pharmacy manager (band 8c)
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Table 2: Delphi statements concerning barriers where consensus was achieved (IQR ≤ 1) 
Statement Median % agreement 
B1 Appropriate review dates for IV antibiotics are not documented on the 
medication chart 
4 76.9% 
B2 Patients are not always reviewed appropriately at the weekends 5 53.8% 
B3 Intravenous antibiotics are not always reviewed daily on ward rounds. 4 53.8% 
B4 Staff are not aware of the intravenous to oral switch guidelines. 4 61.5% 
B5 Staff are unable to access the necessary guidelines. 4 53.8% 
B6 There is no guideline to enable pharmacists to switch intravenous antibiotics 
to the oral route. 
4 53.8% 
B7 Prescribers are not aware of how to find information on suitable oral 
antibiotics following intravenous courses. 
4 53.8% 
B8 There is insufficient monitoring information available to make an informed 
decision to switch to oral antibiotics. 
3 38.5% 
B9 Doubt about the extent of oral absorption prevents an IV to oral switch. 3 30.8% 
B10 Pharmacy staff are not confident enough to encourage the IV to oral switch. 4 30.8% 
B11 Doubt about the safety of a patient’s swallow. 3 53.8% 
B12 Clinical staff are worried that oral antibiotics will not treat the infection 
effectively. 
4 69.2% 
B13 The criteria for reviewing the suitability of a patient for IV to oral switch are 
not specific enough 
3 61.5% 
B14 Variability in clinical judgement in interpreting trends in monitoring 
parameters.  
4 69.2% 
B, barrier; 1, irrelevant; 2, unimportant; 3, unsure; 4, important; 5, very important 
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Table 3: Delphi statements concerning solutions where consensus was achieved (IQR ≤ 1) 
Statement Median % agreement 
S1 Awareness of the intravenous to oral switch guideline must be improved 5 69.2% 
S2 The guideline should be made more accessible on the wards 4 53.8% 
S3 Switch criteria complete with tick boxes should be attached to the 
medication chart to facilitate a decision 
3 53.8% 
S4 Allow pharmacists to order blood tests to facilitate intravenous to oral 
switches 
3 53.8% 
S5 All intravenous antibiotics will be automatically switched to the oral route at 
48 hours. Doctors will have to document if they are to continue on IVs past 
this time 
2 61.5% 
S6 Education on the benefits of IV to oral switch 4 61.5% 
S7 Education sessions using case studies 4 61.5% 
S8 Case specific advice from microbiology to include suggestions for a suitable 
oral option when clinically appropriate 
4 69.2% 
S9 Encourage speech and language therapy referral if in doubt about the 
patient’s swallow 
4 46.2% 
S10 Set out minimum monitoring guidelines for patients on intravenous 
antibiotics to ensure that all information needed to switch from IV to oral is 
available 
4 53.8% 
S11 Minimise outliers so that doctors only have to take responsibility for patients 
on their own ward 
4 46.2% 
S12 Allow doctors more time to review intravenous antibiotics 4 76.9% 
S13 Have guidelines to prevent unnecessary prescribing of IV antibiotics in the 
first place 
4 53.8% 
S14 Medical/ surgical teams to document an antibiotics switch plan to facilitate IV 
to oral switches out of hours 
4 46.2% 
S, solution; 1, irrelevant; 2, unimportant; 3, unsure; 4, important; 5, very important 
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Table 4: Barriers to guideline adherence as identified by interviews 
Internal barriers: knowledge Internal barriers: attitude External barriers 
a) Awareness of the guideline: 
“Well I knew there was one 
but I have never actually 
looked at them directly 
myself.” (Dr2S) 
b) Awareness of patients on 
intravenous antibiotics: 
“As long as we [nurses] 
highlight it to the team if 
sometimes they forget about 
it”(N1M) 
“On a busy ward you just 
think they’re on an antibiotic 
and you kind of don’t look at 
how it’s being given unless 
the nurses flag it up and say 
‘do we really need to give it 
IV?’” (Dr3S) 
c) Perception that oral 
antibiotics are inferior: 
“They’re not as effective, the 
oral antibiotics, that would be 
the main concern.” (Dr 3S) 
a) Low priority: 
“Drugs are often one of the 
last things they [doctors] 
look at in a management 
plan” (Ph2M) 
b) Seniority of decision: 
“Must get follow up from 
above” (Dr3S) 
c) Reassurance of intravenous 
antibiotics: 
“You feel reassured when 
people are on IV antibiotics” 
(Dr2S)  
d) More complex situation than 
is covered by guideline: 
e) Attitude towards guidelines 
in general: 
“Well obviously guidelines 
are only guidelines and they 
are not a rule and they must 
be taken in clinical context” 
(Dr2S) 
a) Interpatient variability: 
b) Time: 
“Occassionally it gets to 72 
hours and you think 
goodness we’ve missed 
that.” (Dr1M) 
“The doctors not having 
time to review the patients 
appropriately I think is 
probably the main barrier.” 
(Ph1M) 
c) Interprofessional 
communication: 
“I think they [the doctors] do 
review at 48 hours but then 
they don’t necessarily 
document that they have 
made that review.” (Ph1M) 
“A lack of communication 
between doctors and 
nurses.” (N2S) 
d) Current guideline: 
“The guidance is vague.” 
(Dr3S) 
Dr, doctor; Ph, pharmacist; N, nurse; M, medical; S, surgical 
Highlighted themes were unique to the interviews 
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Table 5: Solutions to improve guideline adherence as identified by interviews 
Solutions to poor guideline 
adherence 
Sub-themes 
Point of switch reminders a) Visual 
“a nice little IV red stamp on the page...”(Dr1M) 
“The pharmacist could write ‘remember the guidelines or 
something like that.” (Dr2S) 
b) Verbal 
“We can prompt our seniors...” (Dr2S) 
“Highlight it to the team if they forget about it”(N1M) 
Raising primary guideline 
awareness 
a) Target audience 
“I mean it’s just about educating people and talking to the 
junior doctors, talking to the nursing staff...”(Dr3S) 
“...maybe have a big push on MAU and on the surgical 
admissions unit...making the doctors more aware of the 
48hour review.” (Ph1M) 
“...the consultants are missed and they are slow to 
change.”(Dr3S) 
“...teaching to the newly qualified as part of their 
induction.”(N1M) 
b) Methods 
“...you know mention it at grand rounds...”(Dr3S) 
“Maybe just send e-mails if there is any [guideline] changes 
straight away.”(N1M) 
Change guideline “It could be encorporated into the [empirical] antibiotic 
guidelines...you know the protocols”(N2S) 
Engage guideline users “There’s so many guidelines for everything” (Dr3S) 
“Ensure that everyone has read the online guideline” 
“Presenting audit data to them [doctors] on a regular basis per 
consultant. I think medics are very competitive...” (Ph2M) 
Highlight patients on 
intravenous antibiotics 
“Stick something to the front of the drug chart for those people 
who are on IV antibiotics...maybe a little thing above the bed 
even where we say about food intake; IV antibiotics”(Dr1M) 
Dr, doctor; Ph, pharmacist; N, nurse; M, medical; S, surgical; MAU, medical admissions unit 
Highlighted themes were unique to the interviews 
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Appropriate review dates for IV antibiotics are not 
documented on the medication chart. 
Comments from previous rounds: 
The frequency with which antibiotics review dates are 
omitted is decreasing, so I don’t believe it is this that is 
preventing the IV to oral switch in the majority of cases.    
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Comments on this round: 
Please enter comments here 
Figure 1: Example of the format for the third round questionnaire including results from round 2. The 
view taken by the participant in the previous round is indicated with an asterisk, the median value of the 
expert panel is shaded. 
 
